False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidney DonorReportar como inadecuado

False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidney Donor - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Case Reports in Transplantation - Volume 2016 2016, Article ID 4534898, 3 pages -

Case ReportDepartment of Histocompatibility, Amiens University Medical Center, 80000 Amiens, France

Received 2 March 2016; Accepted 13 April 2016

Academic Editor: Gerald Schlaf

Copyright © 2016 Judith Desoutter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Crossmatching is essential prior to kidney transplantation to confirm compatibility between the donor and the recipient, particularly to prevent acute antibody-mediated rejection. An unexpected positive crossmatch may be obtained in recipients with an autoimmune disease or preexisting antibodies not detected by single-antigen bead array due to complement interference or who have been previously treated by desensitization protocols such as rituximab, antithymocyte globulin, or intravenous immunoglobulins. We report donor and recipient investigations that revealed unexpected positive B-cells crossmatch, probably due to donor cells, as the donor had received rituximab therapy shortly before organ harvesting, in a context of severe idiopathic thrombocytopenic purpura. We consequently detected unexpected Class II IgG complement-dependent cytotoxicity for all sera tested. Other laboratory investigations failed to elucidate the reasons for this recipient-related positivity.

Autor: Judith Desoutter, Marie-Joëlle Apithy, Ségolène Bartczak, and Nicolas Guillaume

Fuente: https://www.hindawi.com/


Documentos relacionados